#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyruvate kinase deficiency anaemia Immunodeficiency Myxoid liposarcoma Fragile X syndrome Heritable pulmonary arterial hypertension Retinal dystrophy Arginase deficiency Frostbite Retinitis pigmentosa Immune thrombocytopenia Pemphigus Diffuse large B-cell lymphoma refractory Necrotising enterocolitis neonatal Blastic plasmacytoid dendritic cell neoplasia Urethral valves More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Life with Disease Cytokine release syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Treatment Waldenstrom’s macroglobulinaemia refractory – Treatment Rett syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Basic Information Ewing’s sarcoma – Trials in Disease Angiosarcoma metastatic – Life with Disease Mantle cell lymphoma stage II Lymphatic malformation More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brivaracetam Setrusumab Mrna-3210 Elexacaftor Hu5F9‐G4 Lactose Monohydrate Fingolimod Bosentan Colistimethate Sodium Frexalimab Pelareorep Epirubicin Clozapine Paroxetine Hydrochloride SEVUPARIN Ociperlimab Utreloxastat Hydroxychloroquine Sulfate TRIACYLGLYCEROL LIPASE Etanercept More therapies…

    Learn about Your Condition

    Hepatitis D Medulloblastoma recurrent Glycogen storage disorder Colorectal cancer stage III COVID-19 Scoliosis Arteriospasm coronary Atopic keratoconjunctivitis Dengue fever Diarrhoea Morning sickness Ear discomfort Eyelid ptosis Invasive breast carcinoma Aphthous ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Denmark Germany Spain

  • Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Hereditary ataxia
    Denmark France Portugal Spain

  • Phase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Etripamil
    The Netherlands

  • Phase II study of intratumoral GETACATETIDE in patients with locally advanced or metastatic adrenocortical carcinoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    France Germany Norway Spain

  • Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Pramipexole
    Sweden

  • Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Vinorelbine
    • Bendamustine Hydrochloride
    Denmark
Previous Page
1 … 670 671 672 673 674 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!